Roche Index Blank Site
Roche Diagnostics Contact Legal Statement
Left Navigation
At Your Service

Coagu-Chek Recall mandatory instructions

27 October 2006

 

Product Recall Notice

In vitro Diagnostic Device Recall

Product :  CoaguChekÒ PT-Test 12 Tests Cat. No. 1 1937634190

and

                 CoaguChekÒ PT-Test 48 Tests Cat. No. 1 1937642190

 

Batch/Lot No. : All current strips
Recall Reason :  CoaguChek PT Test Strips – Potential for Erroneous Patient Results Due
to Manufacturing Issue

In rare, isolated cases, use of test strips of the above-named product and pack sizes may result in falsely elevated INR values.

The cause of this error is a production problem. During the coating process in production it is possible that a reduced amount of an active ingredient is applied to the test strips which can lead to falsely elevated INR values. The occurrence of this error is random with an extremely low error frequency (0.001% - this means that in N.Z. we may encounter 1 affected strip per year).  Corrective actions have already been taken which will ensure that the coating on each strip is appropriate. Unfortunately it will take some months until this new process is finally established and test strips without this potential defect are available.

Although the likelihood that you have received such faulty test strips is minimal, we have decided for the sake of your safety, that duplicate testing using different lot numbers - or alternatively different rolls - should be performed whenever you are running a test with your CoaguChek® or CoaguChek® S instrument. 

Health risk :  
In rare isolated cases, use of test strips of the above-named product and pack sizes may result in falsely elevated INR values.

Action to be taken by recipient : 

  • Please find below pictures on how to identify the lot number and roll number, respectively on the test strip box and on the test strip pouch.
  • In case you do not have strips from two different lots or rolls please contact Roche Diagnostics for another CoaguChek® PT test strip box which will be delivered free of charge.
  • The reason for the second test is to ensure the first test is correct.
  • Once you have performed the two tests, refer to the attached guide to determine the allowable differences between your results.
  • If the second result falls within the acceptable range, this will ensure correctness of your first test.
  • If the second result is not within this acceptable range do not initiate treatment until you confirm the test result with an alternative method. Prior to any additional testing contact Roche Diagnostics at 0508 69 5433 for further instructions and to report this discrepancy. 
  • If you have any concerns regarding your treatment, please consult your physician.      
  • The duplicate testing has to be done until strips without this potential defect are available. Shipment of replacement strips will start in January 2007

    CoaguChek® PT Test
    How to identify the lot number and roll number

    coag1

    coag2
    CoaguChek® PT Test
    Test strip box
    Lot number: e.g. 101ARoll number: e.g. D 1
    CoaguChek® PT Test
    Test strip pouch
    Lot number: e.g. 101A Roll number: e.g. D 1

Note:  Always follow package insert instructions to avoid erroneous test results or test errors
from other causes.

Alternatively you can elect to discontinue using your CoaguChek® or CoaguChek® S system until the strips without the defect are available in January and use your local laboratory service.

Please note:  The CoaguChek XS® system is not affected by this issue.  If you have upgraded to a CoaguChek XS® duplicate testing is not required.

If you have any questions regarding the recall, please contact our customer service centre at the following number 0508 MY LIFE (0508 69 5433).
           
Please complete the acknowledgement form below and return to RDNZ.

Details of Compensation:
As already mentioned above the additional costs for the duplicate testing will be covered by Roche Diagnostics.

This removal action has been taken after consultation with the Ministry of Health.

 

We apologise for any inconvenience this may cause and hope for your understanding.

 

B. McEwen                                                                             B. Sheppard
Manager Regulatory Affairs                                                   Product Manager Coagulation



This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.
   
© 2007, Roche Diagnostics New Zealand Ltd See our Legal Statement and our Privacy Statement